Literature DB >> 10770535

Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa.

K Ariyoshi1, S Jaffar, A S Alabi, N Berry, M Schim van der Loeff, S Sabally, P T N'Gom, T Corrah, R Tedder, H Whittle.   

Abstract

OBJECTIVE: To examine whether the levels of plasma RNA and DNA provirus predict the rate of CD4 cell decline and patient death.
DESIGN: Retrospective analysis of HIV-2 cohort subjects.
METHODS: Fifty-two subjects were recruited between January 1991 and December 1992. HIV-2 RNA levels in plasma and DNA levels in peripheral blood mononuclear cells (PBMC) were measured using in-house quantitative PCR assays. The annual rate of CD4 cell decline was calculated using the least-squares method. The survival data on 31 December 1997 were used.
RESULTS: The mean percentage of CD4 cells at baseline was 30.7 (SD, 9.5). In a linear regression model, the annual rate of CD4 cell decline was 1.76 CD4% faster for every increase in one log10 RNA copies/ml [95% confidence interval (CI), 0.81-2.7; P = 0.0006; r = 0.46; n = 52] and 1.76 CD4% faster for every increase in log10 DNA copies/10(5) PBMC (95% CI 0.46-3.1; P = 0.01; r = 0.33; n = 42). In a multiple linear regression model, RNA load was related to CD4 decline independently of DNA load (P = 0.02). The overall mortality rate was 7.29/100 person-years. In a Cox regression model, the hazard rate increased by 2.12 for each log10 increase in RNA load (95% CI, 1.3-3.5; P = 0.0023) but only by 1.09 for each log10 increase in DNA load (95% CI, 0.64-1.87; P = 0.8).
CONCLUSION: This longitudinal study shows for the first time that a baseline HIV-2 RNA load predicts the rate of disease progression. HIV-2-infected patients with a high viral load may need to be treated as vigorously as HIV-1 patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770535     DOI: 10.1097/00002030-200003100-00006

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  20 in total

1.  Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay.

Authors:  Florence Damond; Gilles Collin; Diane Descamps; Sophie Matheron; Sophie Pueyo; Audrey Taieb; Pauline Campa; Antoine Benard; Geneviève Chêne; Francoise Brun-Vezinet
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.

Authors:  Mélanie Bertine; Marie Gueudin; Adeline Mélard; Florence Damond; Diane Descamps; Sophie Matheron; Fidéline Collin; Christine Rouzioux; Jean-Christophe Plantier; Véronique Avettand-Fenoel
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

3.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

4.  Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test.

Authors:  Ming Chang; Katrin Steinmetzer; Dana N Raugi; Robert A Smith; Selly Ba; Fatima Sall; Moussa Seydi; Alassane Niang; ElHadji Ibrahima Sall; Ousseynou Cisse; Katja Rödel; Robert W Coombs; Geoffrey S Gottlieb
Journal:  J Clin Virol       Date:  2017-10-24       Impact factor: 3.168

5.  Quantitative detection of plasma human immunodeficiency virus type 2 subtype A RNA by the Nuclisens EasyQ Assay (version 1.1).

Authors:  Berta Rodés; Julie Sheldon; Carlos Toro; Laureano Cuevas; Esperanza Pérez-Pastrana; Inmaculada Herrera; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

6.  Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa.

Authors:  Geoffrey S Gottlieb; Ndeye Mery Dia Badiane; Stephen E Hawes; Louise Fortes; Macoumba Toure; Cheikh T Ndour; Alison K Starling; Fatou Traore; Fatima Sall; Kim G Wong; Stephen L Cherne; Donovan J Anderson; Stefanie A Dye; Robert A Smith; James I Mullins; Nancy B Kiviat; Papa Salif Sow
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

7.  Differences in proviral DNA load between HIV-1-infected and HIV-2-infected patients.

Authors:  Geoffrey S Gottlieb; Stephen E Hawes; Nancy B Kiviat; Papa Salif Sow
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

8.  Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections.

Authors:  Florence Damond; Marie Gueudin; Sophie Pueyo; Isabelle Farfara; David L Robertson; Diane Descamps; Geneviève Chène; Sophie Matheron; Pauline Campa; Françoise Brun-Vézinet; François Simon
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

9.  Polyfunctional T cell responses are a hallmark of HIV-2 infection.

Authors:  Melody G Duvall; Melissa L Precopio; David A Ambrozak; Assan Jaye; Andrew J McMichael; Hilton C Whittle; Mario Roederer; Sarah L Rowland-Jones; Richard A Koup
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

10.  Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.

Authors:  Jamil S Saad; Sherimay D Ablan; Ruba H Ghanam; Andrew Kim; Kalola Andrews; Kunio Nagashima; Ferri Soheilian; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2008-07-16       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.